Sparrow Pharmaceuticals announced it raised $10 Million in an initial filing from an offering of $15.3 Million

Apr 12, 2024•over 1 year ago

Amount Raised

$10 Million

PortlandHealth Care

Company Information

Company

Sparrow Pharmaceuticals

Location

1050 Southwest 6th Street, Suite 1100

Portland, Oregon, United States

About

Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Sparrow Pharmaceuticals announced it raised $10 Million in an initial filing from an offering of $15.3 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information